Skip to main navigation Skip to search Skip to main content

NEUROCRINE BIOSCIENCES: A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY TOLERABILITY AND EFFICACY OF NBI5788 IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS

Project: Research

Project Details

StatusFinished
Effective start/end date11/1/03 → 06/8/06

Funding

  • Pharmaceutical Research Associates Incorporated: $42,137.00